Loading
DT
Durata Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Shannon John Patrick Jr, was filed 13 Aug 2014.
Durata Therapeutics, Inc.: what insiders have been doing
Durata Therapeutics, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Durata Therapeutics, Inc. in twelve months, the latest record being from 19 November 2014.
Our records for Durata Therapeutics, Inc. go back to 2012, with 13 purchases and 2 sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
62
Thresholds
n/a
Buy Volume
€29M
13 ops. · all time
Sell Volume
€1M
2 ops. · all time
Last declaration on 19 November 2014
Declarations62 total
2,500 sharesCommon StockSEC:0001209191-14-069874:0
15,000 sharesCommon StockSEC:0001209191-14-069840:0
12,500 sharesCommon StockSEC:0001209191-14-069840:1
1,902,030 sharesCommon StockSEC:0001209191-14-070103:0
5,034 sharesCommon StockSEC:0001209191-14-070103:1
5,034 shares@ US$2.08Common StockSEC:0001209191-14-070148:0
1,902,030 sharesCommon StockSEC:0001209191-14-070105:0
5,034 sharesCommon StockSEC:0001209191-14-070105:1
3,006,132 sharesCommon StockSEC:0000904454-14-000759:0
6,250 sharesCommon StockSEC:0000904454-14-000755:0
5,000 sharesCommon StockSEC:0001209191-14-069773:0
45,636 sharesCommon StockSEC:0001209191-14-069759:0
500 sharesCommon StockSEC:0001209191-14-069759:1
13,220 sharesCommon StockSEC:0001209191-14-069757:0
22,306 sharesCommon StockSEC:0000904454-14-000757:0
11,000 sharesCommon StockSEC:0001209191-14-069760:0
24,941 sharesCommon StockSEC:0001209191-14-069772:0
3,028,439 sharesCommon StockSEC:0001012975-14-000749:0
3,000 shares@ US$13.72Common StockSEC:0001209191-14-052202:0
Canonical exit: 10 Nov 2014 (T+90)
3,000 shares@ US$15.23Common StockSEC:0001209191-14-041234:0
Canonical exit: 10 Sept 2014 (T+90)
745,730 shares0Common StockSEC:0000950142-14-001096:0
3,528 shares0Common StockSEC:0000950142-14-001096:1
15,000 shares@ US$15.57Common StockSEC:0001209191-14-033816:0
Canonical exit: 10 Aug 2014 (T+90)
98,000 shares@ US$15.7407Common StockSEC:0000950142-14-000705:0
2,649 shares@ US$15.5738Common StockSEC:0000950142-14-000705:1
25 of 62 declarations
About Durata Therapeutics, Inc.
Durata Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for bacterial infections. It is listed on NASDAQ under the ticker DRTX.
